References
- Factsheet: Malaria: World health organization; 2013 [cited 20 Feb 2014]. Available from: http://www.who.int/mediacentre/factsheets/fs094/en/
- Centers for Disease Control and Prevention. Malaria: about malaria: Malaria Transmission in the United States. CDC; 2010 Feb 8. Available from: http://www.cdc.gov/malaria/about/us_transmission.html
- Schwartz L, Brown GV, Genton B, Moorthy VS. A review of malaria vaccine clinical projects based on the WHO rainbow table. Malar J. 2012 Jan 9 [cited 10 Jan 2014]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22230255
- World Health Organization. World malaria report 2013. WHO; 2013 [cited 12 Jan 2014]. Available from: http://www.who.int/malaria/publications/world_malaria_report_2013/en/
- Ministry of health and family welfare. National Vector borne disease control programme: Malaria Situation. Government of India Directorate general of health sciences Mohfw;2013[Accessed on 21 Feb 2014]. Available from http://nvbdcp.gov.in/Doc/mal-situation-Nov13.pdf
- World health Organization. World malaria report 2011. WHO; 2011 [cited 15 Feb 2014]. Available from: http://www.who.int/malaria/publications/world_malaria_report/en/.
- Carneiro I, Roca-Feltrer A, Griffin JT, Smith L, Tanner M, Schellenberg JA, Greenwood B, Schellenberg D. Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS One 2010; 5:e8988; http://dx.doi.org/10.1371/journal.pone.0008988; PMID: 20126547
- O’Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, Snow RW, Newton CR, Marsh K. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet 2008; 372:1555 - 62; http://dx.doi.org/10.1016/S0140-6736(08)61655-4; PMID: 18984188
- Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJ, Sesay SS, Abubakar I, Dunyo S, Sey O, et al. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet 2008; 372:1545 - 54; http://dx.doi.org/10.1016/S0140-6736(08)61654-2; PMID: 18984187
- Trape JF. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg 2001; 64:Suppl 12 - 7; PMID: 11425173
- World Health Organization. Artemisinin resistance.WHO;2013 [cited 22 Feb 2014]. Available from: http://www.who.int/malaria/areas/drug_resistance/overview/en/
- Otiene C, for the RTS. S Clinical Trials Partnership. Efficacy of RTS, S/AS01 Vaccine Candidate against malaria in African infants and children18 months post-primary vaccination series: a phase III randomized double blind controlled trial (abstract). Multinational Initiative on Malaria, 6th Pan African Malaria Conference, Durban, South Africa, October 6-11, 2013.
- Maire N, Shillcutt SD, Walker DG, Tediosi F, Smith TA. Cost-effectiveness of the introduction of a pre-erythrocytic malaria vaccine into the expanded program on immunization in sub-Saharan Africa: analysis of uncertainties using a stochastic individual-based simulation model of Plasmodium falciparum malaria. Value Health 2011; 14:1028 - 38; http://dx.doi.org/10.1016/j.jval.2011.06.004; PMID: 22152171
- Malaria Vaccine Funders Group. Malaria Vaccine Technology Roadmap. 2013 [cited 15 Feb 2014]. Available from: http://www.who.int/immunization/topics/malaria/vaccine_roadmap/en/